XYXinran Yuan

Xinran Yuan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xinran Yuan has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • Xiaodong Qin

    Nanjing Drum Tower Hospital

    3 shared publications
  • Lingyun Sun

    Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China

    2 shared publications
  • Qi Sun

    Department of Endocrinology and Metabolism, Affiliated Hospital of Nantong University, Nantong, China

    2 shared publications
  • Shu Liu

    Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China

    2 shared publications
  • Yujiao Wang

    Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China

    2 shared publications
  • Bethany Jacobs Wolf

    Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA

    1 shared publication

Latest Publications

  • Open Access

    A multi-criterion feature integration framework for accurate diagnosis of Sjögren’s disease using routine laboratory tests

    by Shu Liu, Guanhao Wu, Mengge Pan, Qi Sun, Chenjing Gao, Xianming Long, Chaogui Tang, Xinran Yuan, Lingyun Sun

    Sjögren’s disease (SjD) is a common systemic autoimmune disease that remains difficult to diagnose early due to non-specific symptoms and lack of definitive biomarkers. This multicentre retrospective cohort study analysed data from 34,958 patients across three hospitals in China to assess the diagnostic potential of routine laboratory tests and to develop a robust, low-cost artificial intelligence model, the Sjögren Multi-criterion Feature Integration Framework (SMFIF). This study is registered with ClinicalTrials.gov (NCT06982482). The model was built using 16 optimal features selected through ensemble learning and SHAP analysis, and validated internally (n = 9329) and externally (n = 545). SMFIF achieved high diagnostic performance, with AUCs of 0.929, 0.934, and 0.964 in testing, internal, and external validation sets, respectively, outperforming conventional biomarkers such as anti-SSA/Ro and ANA. Calibration curves and confusion matrices confirmed its reliability. SMFIF is publicly available and provides probabilities of SjD based on laboratory data, offering a practical diagnostic tool for clinical use.


  • Lupus nephritis as an independent risk factor for carotid atherosclerosis in patients with systemic lupus erythematosus

    by Yujiao Wang, Simin Guo, Yirui Shi, Xiaoquan Wei, Weiwei Chen, Yaqi Zhang, Xinran Yuan, Lingyun Sun

    Objective Systemic lupus erythematosus (SLE) is associated with an elevated risk of atherosclerosis, with lupus nephritis (LN) representing a critical and potentially fatal target organ damage. This study aims to investigate the prevalence of LN in SLE patients, and its correlation with carotid atherosclerosis (CA). Methods A total of 151 SLE patients (age, 50.9 ± 14.6 years, 87.4% women) were included in the study. The 2024 KDIGO guideline was used to assess the LN prevalence, and carotid artery ultrasound was performed to identify plaque and intima-media thickness (IMT). The correlation between LN and CA in SLE patients was evaluated, and logistic regression analysis was conducted to identify CA risk factors. Results A total of 47.0% of SLE patients exhibited LN, and the prevalence of CA was 37.7%. Patients with LN exhibited a higher carotid plaque ratio (47.9% vs 28.7%, p = 0.015) and IMT values [1.0(0.7, 1.1) mm vs. 0.8(0.7, 1.0) mm, p < 0.010] compared to those without LN. The presence of LN (p = 0.002), male sex (p = 0.039), age (p < 0.001), and serum TC (total cholesterol) (p = 0.016) were independent risk factors for SLE patients with CA. LN and related renal parameters demonstrated a strong association with CA in patients with SLE. Conclusion The prevalence of LN was significantly correlated with CA in SLE patients, indicating that early identification of LN in SLE patients has a high risk of CA, which may facilitate targeted prevention and reduce cardiovascular morbidity. Key Points • Lupus nephritis (LN) was present in 47.0% of systemic lupus erythematosus (SLE) patients, and carotid atherosclerosis (CA) was prevalent in 37.7% of the study. • Systemic lupus erythematosus (SLE) patients with lupus nephritis (LN) exhibited significantly higher carotid plaque ratios and increased intima-media thickness compared to those without LN. • The presence of lupus nephritis (LN), male sex, advanced age, and elevated total cholesterol levels was identified as independent risk factors for carotid atherosclerosis (CA) in patients with systemic lupus erythematosus (SLE).


  • Open Access

    Human CD141 + dendritic cells: A unique tolerogenic subset inducing immune tolerance in systemic lupus erythematosus patients

    by Xiaodong Qin, Yujiao Wang, Yi Chen, Dong Xie, Xinran Yuan

    Background: Tolerogenic dendritic cells (DCs) are promising for cell‐based treatment for systemic lupus erythematosus (SLE). We previously showed that tolerogenic CD1c + DCs play an important role in mesenchymal stem cell transplantation treatment of SLE. We further investigated the immunoregulatory effects of CD141 + DCs on lupus pathogenesis. Methods: A total of 12 SLE patients and 12 age‐ and sex‐matched healthy subjects were included in the Affiliated Drum Tower Hospital of Nanjing University Medical School from January 2019 to January 2021. The percentage of peripheral blood CD141 + DCs and their functional expressions of costimulatory markers (CD40, CD80, CD83, and CD86) were compared between patients with SLE and healthy controls. Moreover, the tolerogenic properties of CD141 + and CD1c + DCs were compared following stimulation with lipopolysaccharide (LPS) or SLE serum. Results: Our research revealed that the presence of peripheral CD141 + DCs decreased in SLE patients compared with controls (1.03% ± 0.40% vs. 1.44% ± 0.36%, p < 0.05), which was negatively correlated with the SLE disease activity index score ( R 2 = 0.5547, p = 0.0055). Moreover, CD141 + DCs in patients with SLE exhibited distinct tolerogenic properties by decreasing the mean fluorescence intensity (MFI) of CD40, CD80, and CD86 when compared with controls (2447.00 ± 1386.14 vs. 11,357.25 ± 4581.05, p < 0.001; 1528.00 ± 876.61 vs. 14,181.42 ± 7599.33, p < 0.001; 17,409.42 ± 8180.98 vs. 33,614.25 ± 7408.69, p < 0.001). Furthermore, CD141 + DCs exhibited superior tolerogenicity when compared to CD1c + DCs in SLE, by reducing MFI of CD86 (93,526.58 ± 51,763.00 vs. 169,552.00 ± 51,225.74, p < 0.01 by LPS stimulation; 107,837.40 ± 26,124.76 vs. 145,450.90 ± 50,436.69, p < 0.05 by SLE serum stimulation), and reducing production of tumor necrosis factor α (8.83% ± 3.51% vs. 13.94% ± 2.87%, p < 0.05 by LPS stimulation; 10.12% ± 2.34% vs. 14.39% ± 2.70%, p < 0.05 by SLE serum stimulation). Conclusions: CD141 + DCs play a more significant role than the commonly studied CD1c + DCs in ameliorating immune dysfunction and maintaining immune homeostasis in SLE. Our findings contribute to a better understanding of the immunoregulatory mechanisms underlying SLE and pave the way for novel therapeutic approaches targeting CD141 + DCs.

  • Human hypofunctional NCF1 variants promote pulmonary fibrosis in the bleomycin-induced mouse model and patients with systemic sclerosis via expansion of SPP1+ monocytes-derived macrophages

    by Xinran Yuan, Xiaodong Qin, Kenji Takemoto, Jian Zhao, Matthew Sanderson, Xue Xu, Yu Zhang, Kristi L. Helke, Bethany Jacobs Wolf, Joel M. Guthridge, et al.

    We assessed the role of a systemic lupus erythematosus causal hypofunctional variant, neutrophil cytosolic factor 1 (NCF1)-p.Arg90His (p.R90H) substitution, in systemic sclerosis (SSc). Association of NCF1-H90 with SSc was performed in case-control cohorts, bleomycin (BLM)-treated Ncf1-R90 C57BL/6 wildtype and Ncf1-H90 knock-in (KI) littermates. Peripheral blood mononuclear cell (PBMC) subsets were analysed by cytometry by time-of-flight. The NCF1-H90 allele is associated with risk for diffuse cutaneous SSc (dcSSc) in Chinese and European Americans, and lung fibrosis in Chinese patients with SSc (OR=2.09, p=7.96E-10). Low copy number of NCF1 associated with lung fibrosis in European Americans (OR=4.33, p=2.60E-2). BLM-treated KI mice demonstrated increased pulmonary fibrosis, exhibiting activated type I interferon signature, elevated Spp1, Ccl2, Arg1, Timp1 and Il6 expression, enriched macrophage scores in lung tissues. In a longitudinal observation cohort, homozygous H90 patients with SSc at baseline had increased anti-nuclear antibody titres, anti-topoisomerase antibody seropositivity and anti-centromere antibody seronegativity, increased incidence of lung fibrosis and Gender-Age-lung Physiology index, elevated modified Rodnan Skin Score (mRSS) and elevated plasma osteopontin (OPN, SPP1), CCL2, ARG1, TIMP-1 and IL-6. These H90 patients with SSc sustained elevated mRSS during follow-up years with decreased survival. The 0, 1 and 2 copies of H90 carriage in SSc PBMCs exhibited dose-dependent increases in profibrotic CD14+CD68+CD11b+Tim3+monocytes. Elevated OPN, CCL2 and ARG1 in CD68+CD11b+monocyte-derived macrophages from H90 patients were decreased after co-culturing with anti-CCL2 antibody. Low NCF1 activity increases the risk for the development of dcSSc and lung fibrosis via expanding profibrotic SPP1+MoMs in a CCL2-dependent manner, contributing to the severity of lung fibrosis in both BLM-treated mice and patients with SSc.


  • Open Access

    Hypothyroidism is a causal determinant of age-related cataract risk in European population: a Mendelian randomization study

    by Shu Liu, Qi Sun, Qingwei Gu, Yujie Bao, Wei Wang, Xiaodong Qin, Xinran Yuan

    Objective: To determine whether there is a causal relationship between thyroid dysfunction and the risk of age-related cataract (ARC) in the European population.Design: A two-sample Mendelian randomization (MR) study.Methods: Hypothyroidism, hyperthyroidism, free thyroxine (fT4), and thyrotropin (TSH) were selected as exposures. The single nucleotide polymorphisms (SNP) of hypothyroidism and hyperthyroidism were obtained from the genome-wide association studies (GWAS) of the IEU database, including 337,159 subjects. Data for fT4 and TSH (72,167 subjects) were extracted from the ThyroidOmics Consortium. ARC was used as the outcome. The SNPs associated with ARC were selected from a GWAS of 216,362 individuals in the FinnGen database. The main method used was the inverse variance-weighted method, together with four complementary methods. Sensitivity analyses were performed using Cochran’s Q test, MR-PRESSO, MR-Egger regression and leave-one-out test. MR pleiotropy was used to test for pleiotropy. MR Steiger test was used to test for the directionality.Results: Two-sample MR analysis revealed a positive association between genetically predicted hypothyroidism and risk of ARC (OR = 2.501, 95% CI: 1.325-4.720; P = 0.004). Hyperthyroidism, circulating fT4 and TSH levels did not have a significant causal effect on ARC (P > 0.05). The results were robust and reliable, and no horizontal pleiotropy was found after sensitivity analyses. In the MR Steiger test, we found no reverse causal effects of hypothyroidism on the ARC (P <0.001).Conclusions: Our study provides strong evidence that hypothyroidism is a causal determinant of ARC risk.